FDA ready for Plan B in leadership?

The Food and Drug Administration Commissioner Lester Crawford is fooling no one with the latest delay in allowing Plan B, the "morning-after" pill, to be sold over the counter, though he says it wants more study and public input. This is White House stalling that has all to do with abortion politics and nothing to do with women’s health or science. As assistant commissioner Susan Wood said in quitting over the delay last week, I can "no longer serve as staff when scientific and clinical evidence, fully evaluated and recommended for approval by the professional staff here, has been overruled."
Posted by Rhonda Holman

2 Comments

  1. Posted September 6, 2005 at 8:10 am | Permalink

    It’s just part of “intelligent design”.

  2. ProudMan
    Posted September 6, 2005 at 10:21 pm | Permalink

    Since when did the FDA exist to ensure drugs are safe? They piddle on one for 7+ years before approval. Then go out and proclaim, “It will save 10,000 lives per year.” They just don’t say it the 70,000 people who died over the previous seven years. Drug companies don’t enter those trials with the FDA without knowing the results ahead of time. At least not successful ones.

    That said, it’s (FDA) a political institution not a health and safety board.